As introduced: - Establishes the Board of Autonomous Medical Practice to license and regulate artificial intelligence augmented and autonomous service providers (AAASPs). - Creates a mandatory licensing framework for entities operating certain clinical AI services, with license classes based on function and U.S. Food and Drug Administration clearance status. - Authorizes certain licensed AAASPs to issue clinical orders and prescriptions for non-controlled substances. - Waives the corporate practice of medicine doctrine for licensed AAASPs and limits liability for noneconomic damages for providers operating under a provisional license. - Requires state Medicaid and private health carriers to establish reimbursement mechanisms and cover medically necessary services provided by licensed AAASPs.
| Date | Chamber | Action |
|---|---|---|
Apr 1, 2026 | H | Hearing Scheduled - Appropriations |
Mar 24, 2026 | H | Hearing Scheduled - Appropriations (Sorensen Ch, Meyer, A., Zabner) |
Mar 24, 2026 | — | Subcommittee recommends passage. |
Mar 19, 2026 | — | Subcommittee Meeting: 03/24/2026 12:00PM RM 304. |
Mar 18, 2026 | — | Subcommittee: Sorensen, Meyer, A. and Zabner. H.J. 686. |
Mar 18, 2026 | — | Introduced, referred to Appropriations. H.J. 685. |
| Last Action | Mar 24, 2026 |
|---|---|
| Year | 2025 |
| Bill Type | Bill |
| Created | Mar 21, 2026 |
| Updated | Mar 31, 2026 |